Perioperative Management of Pheochromocytoma and Catecholamine-Induced Dilated Cardiomyopathy in a Pediatric Patient

[1]  G. Arnaldi,et al.  Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. , 2009, The Journal of clinical endocrinology and metabolism.

[2]  D. Berney,et al.  Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours. , 2009, Endocrine-related cancer.

[3]  Simon Nadel,et al.  Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine* , 2009, Critical care medicine.

[4]  V. Mai,et al.  Catecholamine-induced cardiomyopathy. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[5]  Kentaro Takahashi,et al.  Von Hippel-Lindau Disease , 2024 .

[6]  M. Singer,et al.  Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care ( PAC-Man ) : a randomised controlled trial , 2022 .

[7]  R. Brant,et al.  A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. , 2003, The New England journal of medicine.

[8]  J. Schipper,et al.  Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.

[9]  J. Tobias,et al.  Cerebrovascular event, dilated cardiomyopathy, and pheochromocytoma , 2002, Pediatric emergency care.

[10]  A. Vortmeyer,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes , 2022 .

[11]  W. Neblett,et al.  Twenty-Five-Year Surgical Experience with Pheochromocytoma in Children , 2000, The American surgeon.

[12]  D. Schroeder,et al.  Perianesthetic Risks and Outcomes of Pheochromocytoma and Paraganglioma Resection , 2000, Anesthesia and analgesia.

[13]  P. Choyke,et al.  von Hippel-Lindau disease: genetic, clinical, and imaging features. , 1995, Radiology.

[14]  K. Lam,et al.  A review of clinicopathologic features of pheochromocytomas in Hong Kong Chinese. , 1993, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  E. Lieberman,et al.  The Perioperative Management of Pheochromocytoma in Children , 1992, Clinical pediatrics.

[16]  D. Goldstein,et al.  Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. , 1987, The New England journal of medicine.

[17]  F. Gilsanz,et al.  Cardiomyopathy and phaeochromocytoma , 1983, Anaesthesia.

[18]  F. Mihm.  PULMONARY ARTERY PRESSURE MONITORING IN PATIENTS WITH PHEOCHROMOCYTOMA , 1982 .

[19]  R. Rowe,et al.  Catecholamine cardiomyopathy: an unusual presentation of pheochromocytoma in children. , 1981, The Journal of pediatrics.

[20]  M. Melicow,et al.  Pheochromocytoma in children , 1963 .

[21]  J. Balfe,et al.  Pediatric pheochromocytoma , 2005, Pediatric Surgery International.

[22]  J. Balfe,et al.  Pediatric pheochromocytoma. A 36-year review. , 1997, Pediatric surgery international.

[23]  G. Rona.  Catecholamine cardiotoxicity. , 1985, Journal of molecular and cellular cardiology.

[24]  B. Thompson,et al.  Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. , 1984, Archives of internal medicine.

[25]  S. Downing,et al.  Inotropic responsiveness of the heart in catecholamine cardiomyopathy. , 1981, American heart journal.

[26]  O. Pachinger,et al.  Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions. , 1973, Recent advances in studies on cardiac structure and metabolism.